{"entity":{"type":"insider","cik":"0001373603","url":"/insider/0001373603","json_url":"/insider/0001373603.json","name":"Leonard Braden Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":224,"n_filings":108,"first":"2009-11-25","last":"2026-04-27","span_basis":"filed_date"},"name_variants":[{"name":"Leonard Braden Michael","source":"filing","n_filings":108,"first_seen":"2009-11-25","last_seen":"2026-04-27"}],"transactions":[{"id":5888853,"accession":"0001373604-26-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-26-000034","line_url":"/filing/0001373604-26-000034#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":4.53,"price_display":"4.53","price_state":"stated","total_value":1359000.0,"total_display":"1,359,000.00","shares_owned_after":13950000.0,"shares_owned_after_display":"13,950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-23","filed_date":"2026-04-27","scope":"insider"},{"id":4049997,"accession":"0001373604-25-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000122","line_url":"/filing/0001373604-25-000122#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524560.0,"shares_display":"524,560","price_per_share":4.1947,"price_display":"4.19","price_state":"stated","total_value":2200371.832,"total_display":"2,200,371.83","shares_owned_after":1958080.0,"shares_owned_after_display":"1,958,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider"},{"id":4768555,"accession":"0001373604-25-000118","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001373604-25-000118","line_url":"/filing/0001373604-25-000118#line-3","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":222925.0,"shares_display":"222,925","price_per_share":4.17,"price_display":"4.17","price_state":"stated","total_value":929597.25,"total_display":"929,597.25","shares_owned_after":2428640.0,"shares_owned_after_display":"2,428,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-03","scope":"insider"},{"id":4768550,"accession":"0001373604-25-000118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000118","line_url":"/filing/0001373604-25-000118#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51961.0,"shares_display":"51,961","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":218236.2,"total_display":"218,236.20","shares_owned_after":2705565.0,"shares_owned_after_display":"2,705,565","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-03","scope":"insider"},{"id":4768546,"accession":"0001373604-25-000118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000118","line_url":"/filing/0001373604-25-000118#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":1260000.0,"total_display":"1,260,000.00","shares_owned_after":2757526.0,"shares_owned_after_display":"2,757,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4107258,"accession":"0001373604-25-000106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000106","line_url":"/filing/0001373604-25-000106#line-2","is_derivative":false,"issuer_cik":"0001001907","issuer_name":"ASTROTECH Corp","issuer_ticker":"ASTC","issuer_name_source":null,"issuer_url":"/issuer/0001001907","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220410.0,"shares_display":"220,410","price_per_share":7.1305,"price_display":"7.13","price_state":"stated","total_value":1571633.505,"total_display":"1,571,633.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":4107253,"accession":"0001373604-25-000106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000106","line_url":"/filing/0001373604-25-000106#line-1","is_derivative":false,"issuer_cik":"0001001907","issuer_name":"ASTROTECH Corp","issuer_ticker":"ASTC","issuer_name_source":null,"issuer_url":"/issuer/0001001907","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9166.0,"shares_display":"9,166","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":53437.78,"total_display":"53,437.78","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":5151902,"accession":"0001373604-25-000084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001373604-25-000084","line_url":"/filing/0001373604-25-000084#line-4","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":425000.0,"shares_display":"425,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":429250.0,"total_display":"429,250.00","shares_owned_after":3224432.0,"shares_owned_after_display":"3,224,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-05-30","scope":"insider"},{"id":5151897,"accession":"0001373604-25-000084","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001373604-25-000084","line_url":"/filing/0001373604-25-000084#line-3","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":1.0324,"price_display":"1.03","price_state":"stated","total_value":7226.8,"total_display":"7,226.80","shares_owned_after":3217432.0,"shares_owned_after_display":"3,217,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-05-30","scope":"insider"},{"id":5151893,"accession":"0001373604-25-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000084","line_url":"/filing/0001373604-25-000084#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":2320000.0,"total_display":"2,320,000.00","shares_owned_after":3749432.0,"shares_owned_after_display":"3,749,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-30","scope":"insider"},{"id":5151889,"accession":"0001373604-25-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000084","line_url":"/filing/0001373604-25-000084#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":116000.0,"total_display":"116,000.00","shares_owned_after":3649432.0,"shares_owned_after_display":"3,649,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-30","scope":"insider"},{"id":5037150,"accession":"0001373604-25-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000090","line_url":"/filing/0001373604-25-000090#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":1.09,"price_display":"1.09","price_state":"stated","total_value":218000.0,"total_display":"218,000.00","shares_owned_after":3017432.0,"shares_owned_after_display":"3,017,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-06-16","scope":"insider"},{"id":4804188,"accession":"0001373604-25-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000065","line_url":"/filing/0001373604-25-000065#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.979,"price_display":"2.98","price_state":"stated","total_value":148950.0,"total_display":"148,950.00","shares_owned_after":191800.0,"shares_owned_after_display":"191,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-23","filed_date":"2025-04-24","scope":"insider"},{"id":4804181,"accession":"0001373604-25-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000065","line_url":"/filing/0001373604-25-000065#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","shares_owned_after":3057526.0,"shares_owned_after_display":"3,057,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-24","scope":"insider"},{"id":4705333,"accession":"0001373604-25-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000058","line_url":"/filing/0001373604-25-000058#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15209.0,"shares_display":"15,209","price_per_share":4.0376,"price_display":"4.04","price_state":"stated","total_value":61407.8584,"total_display":"61,407.86","shares_owned_after":2757526.0,"shares_owned_after_display":"2,757,526","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-02","scope":"insider"},{"id":4705316,"accession":"0001373604-25-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000058","line_url":"/filing/0001373604-25-000058#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19566.0,"shares_display":"19,566","price_per_share":4.3784,"price_display":"4.38","price_state":"stated","total_value":85667.7744,"total_display":"85,667.77","shares_owned_after":2742317.0,"shares_owned_after_display":"2,742,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-31","filed_date":"2025-04-02","scope":"insider"},{"id":9285491,"accession":"0001373604-25-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000069","line_url":"/filing/0001373604-25-000069#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16593.0,"shares_display":"16,593","price_per_share":5.1883,"price_display":"5.19","price_state":"stated","total_value":86089.4619,"total_display":"86,089.46","shares_owned_after":141800.0,"shares_owned_after_display":"141,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-04-28","scope":"insider"},{"id":5037145,"accession":"0001373604-25-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000056","line_url":"/filing/0001373604-25-000056#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16593.0,"shares_display":"16,593","price_per_share":5.1883,"price_display":"5.19","price_state":"stated","total_value":86089.4619,"total_display":"86,089.46","shares_owned_after":141800.0,"shares_owned_after_display":"141,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-27","scope":"insider"},{"id":4768541,"accession":"0001373604-25-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000067","line_url":"/filing/0001373604-25-000067#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16593.0,"shares_display":"16,593","price_per_share":5.1883,"price_display":"5.19","price_state":"stated","total_value":86089.4619,"total_display":"86,089.46","shares_owned_after":141800.0,"shares_owned_after_display":"141,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-04-28","scope":"insider"},{"id":9285490,"accession":"0001373604-25-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000069","line_url":"/filing/0001373604-25-000069#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20407.0,"shares_display":"20,407","price_per_share":5.0395,"price_display":"5.04","price_state":"stated","total_value":102841.0765,"total_display":"102,841.08","shares_owned_after":125207.0,"shares_owned_after_display":"125,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-04-28","scope":"insider"},{"id":5037139,"accession":"0001373604-25-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000056","line_url":"/filing/0001373604-25-000056#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20407.0,"shares_display":"20,407","price_per_share":5.0395,"price_display":"5.04","price_state":"stated","total_value":102841.0765,"total_display":"102,841.08","shares_owned_after":125207.0,"shares_owned_after_display":"125,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-27","scope":"insider"},{"id":4768536,"accession":"0001373604-25-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000067","line_url":"/filing/0001373604-25-000067#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20407.0,"shares_display":"20,407","price_per_share":5.0395,"price_display":"5.04","price_state":"stated","total_value":102841.0765,"total_display":"102,841.08","shares_owned_after":125207.0,"shares_owned_after_display":"125,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-04-28","scope":"insider"},{"id":4554451,"accession":"0001373604-25-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001373604-25-000051","line_url":"/filing/0001373604-25-000051#line-4","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stovk","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30600.0,"shares_display":"30,600","price_per_share":5.6133,"price_display":"5.61","price_state":"stated","total_value":171766.98,"total_display":"171,766.98","shares_owned_after":2722761.0,"shares_owned_after_display":"2,722,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-20","scope":"insider"},{"id":4554446,"accession":"0001373604-25-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001373604-25-000051","line_url":"/filing/0001373604-25-000051#line-3","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.9356,"price_display":"4.94","price_state":"stated","total_value":123390.0,"total_display":"123,390.00","shares_owned_after":2692161.0,"shares_owned_after_display":"2,692,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":4554442,"accession":"0001373604-25-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000051","line_url":"/filing/0001373604-25-000051#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44341.0,"shares_display":"44,341","price_per_share":4.7274,"price_display":"4.73","price_state":"stated","total_value":209617.6434,"total_display":"209,617.64","shares_owned_after":2667161.0,"shares_owned_after_display":"2,667,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":4554436,"accession":"0001373604-25-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000051","line_url":"/filing/0001373604-25-000051#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":82800.0,"total_display":"82,800.00","shares_owned_after":2622820.0,"shares_owned_after_display":"2,622,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":4073895,"accession":"0001373604-25-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001373604-25-000041","line_url":"/filing/0001373604-25-000041#line-3","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85068.0,"shares_display":"85,068","price_per_share":4.5965,"price_display":"4.60","price_state":"stated","total_value":391015.062,"total_display":"391,015.06","shares_owned_after":2604820.0,"shares_owned_after_display":"2,604,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-02-28","scope":"insider"},{"id":4073893,"accession":"0001373604-25-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-25-000041","line_url":"/filing/0001373604-25-000041#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86802.0,"shares_display":"86,802","price_per_share":4.4595,"price_display":"4.46","price_state":"stated","total_value":387093.519,"total_display":"387,093.52","shares_owned_after":2519752.0,"shares_owned_after_display":"2,519,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-02-28","scope":"insider"},{"id":4073891,"accession":"0001373604-25-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-25-000041","line_url":"/filing/0001373604-25-000041#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":164886.0,"shares_display":"164,886","price_per_share":4.0087,"price_display":"4.01","price_state":"stated","total_value":660978.5082,"total_display":"660,978.51","shares_owned_after":2432950.0,"shares_owned_after_display":"2,432,950","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-26","filed_date":"2025-02-28","scope":"insider"},{"id":2947377,"accession":"0001373604-24-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000098","line_url":"/filing/0001373604-24-000098#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68746.0,"shares_display":"68,746","price_per_share":1.4964,"price_display":"1.50","price_state":"stated","total_value":102871.5144,"total_display":"102,871.51","shares_owned_after":3457395.0,"shares_owned_after_display":"3,457,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-25","filed_date":"2024-09-26","scope":"insider"},{"id":2947374,"accession":"0001373604-24-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000098","line_url":"/filing/0001373604-24-000098#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29600.0,"shares_display":"29,600","price_per_share":1.4144,"price_display":"1.41","price_state":"stated","total_value":41866.24,"total_display":"41,866.24","shares_owned_after":3388649.0,"shares_owned_after_display":"3,388,649","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-24","filed_date":"2024-09-26","scope":"insider"},{"id":2439630,"accession":"0001373604-24-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000094","line_url":"/filing/0001373604-24-000094#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":806.0,"shares_display":"806","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":1128.4,"total_display":"1,128.40","shares_owned_after":3359049.0,"shares_owned_after_display":"3,359,049","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":2439627,"accession":"0001373604-24-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000094","line_url":"/filing/0001373604-24-000094#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55300.0,"shares_display":"55,300","price_per_share":1.3582,"price_display":"1.36","price_state":"stated","total_value":75108.46,"total_display":"75,108.46","shares_owned_after":3358243.0,"shares_owned_after_display":"3,358,243","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-19","scope":"insider"},{"id":2920437,"accession":"0001373604-24-000090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001373604-24-000090","line_url":"/filing/0001373604-24-000090#line-3","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":172747.0,"shares_display":"172,747","price_per_share":1.3712,"price_display":"1.37","price_state":"stated","total_value":236870.6864,"total_display":"236,870.69","shares_owned_after":3302943.0,"shares_owned_after_display":"3,302,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-16","scope":"insider"},{"id":2920431,"accession":"0001373604-24-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000090","line_url":"/filing/0001373604-24-000090#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.313,"price_display":"1.31","price_state":"stated","total_value":196950.0,"total_display":"196,950.00","shares_owned_after":3130196.0,"shares_owned_after_display":"3,130,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-16","scope":"insider"},{"id":2920427,"accession":"0001373604-24-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000090","line_url":"/filing/0001373604-24-000090#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36176.0,"shares_display":"36,176","price_per_share":1.3966,"price_display":"1.40","price_state":"stated","total_value":50523.4016,"total_display":"50,523.40","shares_owned_after":2980196.0,"shares_owned_after_display":"2,980,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":3080057,"accession":"0001373604-24-000088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000088","line_url":"/filing/0001373604-24-000088#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.484,"price_display":"1.48","price_state":"stated","total_value":37100.0,"total_display":"37,100.00","shares_owned_after":248702.0,"shares_owned_after_display":"248,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-09","scope":"insider"},{"id":3080055,"accession":"0001373604-24-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000088","line_url":"/filing/0001373604-24-000088#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5100.0,"shares_display":"5,100","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":7140.0,"total_display":"7,140.00","shares_owned_after":223702.0,"shares_owned_after_display":"223,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-05","filed_date":"2024-09-09","scope":"insider"},{"id":2216236,"accession":"0001373604-24-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000086","line_url":"/filing/0001373604-24-000086#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","shares_owned_after":218602.0,"shares_owned_after_display":"218,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":3080050,"accession":"0001373604-24-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000084","line_url":"/filing/0001373604-24-000084#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":151.0,"shares_display":"151","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":641.75,"total_display":"641.75","shares_owned_after":218602.0,"shares_owned_after_display":"218,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-30","filed_date":"2024-09-04","scope":"insider"},{"id":3080045,"accession":"0001373604-24-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000081","line_url":"/filing/0001373604-24-000081#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1215.0,"shares_display":"1,215","price_per_share":3.9627,"price_display":"3.96","price_state":"stated","total_value":4814.6805,"total_display":"4,814.68","shares_owned_after":217951.0,"shares_owned_after_display":"217,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-28","scope":"insider"},{"id":3080041,"accession":"0001373604-24-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000081","line_url":"/filing/0001373604-24-000081#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Talis Biomedical Corp","issuer_ticker":"TLIS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13167.0,"shares_display":"13,167","price_per_share":3.8978,"price_display":"3.90","price_state":"stated","total_value":51322.3326,"total_display":"51,322.33","shares_owned_after":216736.0,"shares_owned_after_display":"216,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-28","scope":"insider"},{"id":2920421,"accession":"0001373604-24-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000066","line_url":"/filing/0001373604-24-000066#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.04,"price_display":"1.04","price_state":"stated","total_value":1560000.0,"total_display":"1,560,000.00","shares_owned_after":5749432.0,"shares_owned_after_display":"5,749,432","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider"},{"id":2439622,"accession":"0001373604-24-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000071","line_url":"/filing/0001373604-24-000071#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100487.0,"shares_display":"100,487","price_per_share":1.4132,"price_display":"1.41","price_state":"stated","total_value":142008.2284,"total_display":"142,008.23","shares_owned_after":2944020.0,"shares_owned_after_display":"2,944,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-14","scope":"insider"},{"id":2439618,"accession":"0001373604-24-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000071","line_url":"/filing/0001373604-24-000071#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":171339.0,"shares_display":"171,339","price_per_share":1.3925,"price_display":"1.39","price_state":"stated","total_value":238589.5575,"total_display":"238,589.56","shares_owned_after":2843533.0,"shares_owned_after_display":"2,843,533","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-14","scope":"insider"},{"id":2216230,"accession":"0001373604-24-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000060","line_url":"/filing/0001373604-24-000060#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":206025.0,"shares_display":"206,025","price_per_share":1.2443,"price_display":"1.24","price_state":"stated","total_value":256356.9075,"total_display":"256,356.91","shares_owned_after":14250000.0,"shares_owned_after_display":"14,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-05","scope":"insider"},{"id":2216228,"accession":"0001373604-24-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000060","line_url":"/filing/0001373604-24-000060#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":167544.0,"shares_display":"167,544","price_per_share":1.2916,"price_display":"1.29","price_state":"stated","total_value":216399.8304,"total_display":"216,399.83","shares_owned_after":14043975.0,"shares_owned_after_display":"14,043,975","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-02","filed_date":"2024-08-05","scope":"insider"},{"id":3250974,"accession":"0001373604-24-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001373604-24-000056","line_url":"/filing/0001373604-24-000056#line-2","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.3264,"price_display":"1.33","price_state":"stated","total_value":132640.0,"total_display":"132,640.00","shares_owned_after":13876421.0,"shares_owned_after_display":"13,876,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-31","filed_date":"2024-07-31","scope":"insider"},{"id":3250967,"accession":"0001373604-24-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000056","line_url":"/filing/0001373604-24-000056#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":173730.0,"shares_display":"173,730","price_per_share":1.303,"price_display":"1.30","price_state":"stated","total_value":226370.19,"total_display":"226,370.19","shares_owned_after":13776421.0,"shares_owned_after_display":"13,776,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider"},{"id":2521490,"accession":"0001373604-24-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001373604-24-000058","line_url":"/filing/0001373604-24-000058#line-1","is_derivative":false,"issuer_cik":"0001373603","issuer_name":"Adverum Biotechnologies, Inc.","issuer_ticker":"ADVM","issuer_name_source":null,"issuer_url":"/issuer/0001373603","owner_cik":"0001373603","owner_name":"Leonard Braden Michael","owner_url":"/insider/0001373603","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85800.0,"shares_display":"85,800","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":613470.0,"total_display":"613,470.00","shares_owned_after":2268064.0,"shares_owned_after_display":"2,268,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider"}],"next_cursor":"2024-07-30|2521490","ledger_fault":false,"count":{"value":217,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":144,"open_market":true},{"code":"S","label":"Open-market sale","n":73,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":217},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Ten percent owner","n_filings":8,"first_seen":"2024-06-13","last_seen":"2026-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Adverum Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner","n_filings":11,"first_seen":"2024-07-18","last_seen":"2025-12-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001001907","name":"ASTROTECH Corp","url":"/issuer/0001001907","role":"Ten percent owner","n_filings":8,"first_seen":"2022-08-25","last_seen":"2025-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001880438","name":"AN2 Therapeutics, Inc.","url":"/issuer/0001880438","role":"Ten percent owner","n_filings":3,"first_seen":"2024-08-14","last_seen":"2025-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"Reneo Pharmaceuticals, Inc.","url":"/issuer/0001637715","role":"Ten percent owner","n_filings":5,"first_seen":"2024-05-16","last_seen":"2024-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001584751","name":"Talis Biomedical Corp","url":"/issuer/0001584751","role":"Ten percent owner","n_filings":4,"first_seen":"2024-08-28","last_seen":"2024-09-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001681087","name":"AVROBIO, Inc.","url":"/issuer/0001681087","role":"Ten percent owner","n_filings":1,"first_seen":"2024-05-15","last_seen":"2024-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001662244","name":"Cyteir Therapeutics, Inc.","url":"/issuer/0001662244","role":"Ten percent owner","n_filings":2,"first_seen":"2024-03-19","last_seen":"2024-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Ten percent owner","n_filings":9,"first_seen":"2022-04-25","last_seen":"2023-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0000946563","name":"RETRACTABLE TECHNOLOGIES INC","url":"/issuer/0000946563","role":"Ten percent owner","n_filings":7,"first_seen":"2022-05-02","last_seen":"2022-12-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001634379","name":"Metacrine, Inc.","url":"/issuer/0001634379","role":"Ten percent owner","n_filings":4,"first_seen":"2022-10-26","last_seen":"2022-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001692830","name":"Satsuma Pharmaceuticals, Inc.","url":"/issuer/0001692830","role":"Ten percent owner","n_filings":2,"first_seen":"2022-11-16","last_seen":"2022-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Gemini Therapeutics, Inc. /DE","url":"/issuer/0001816736","role":"Ten percent owner","n_filings":2,"first_seen":"2022-04-13","last_seen":"2022-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000868278","name":"ProPhase Labs, Inc.","url":"/issuer/0000868278","role":"Ten percent owner","n_filings":7,"first_seen":"2014-09-15","last_seen":"2017-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001113809","name":"BUILD A BEAR WORKSHOP INC","url":"/issuer/0001113809","role":"Director, Ten percent owner, Other","n_filings":35,"first_seen":"2009-11-25","last_seen":"2017-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001373603","retrieved_at":"2026-08-21T09:40:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}